Shows
Pfizer Industry NewsPfizer's Stock Dips, but Analysts See Upside Ahead - Exploring the Factors Shaping Pharma Giant's FutureAs of today, June 19, 2025, Pfizer's stock is trading at $24.00 per share on the New York Stock Exchange. This price reflects a slight decrease from the previous day's closing price of $24.40, according to Morningstar. The trading volume for Pfizer stock has been substantial, with 39,344,718 shares changing hands on June 13, 2025, as reported by Pfizer's investor relations website.Pfizer's current stock price is also notable for its discount compared to its fair value. Morningstar estimates Pfizer's fair value at $64.00, indicating a significant discount of 62 percent. This discrepancy could be influenced by various factors, including investor sentiment and market conditions....2025-06-1902 minPfizer Industry NewsPfizer's Promising Prospects: Navigating the Evolving Pharmaceutical LandscapeAs of April 23, 2025, Pfizer's stock price is $22.14, which is slightly lower than its closing price of $22.14 on April 17, 2025, according to the latest data from Pfizer's investor relations website. The trading volume on April 17, 2025, was 54,073,683 shares, which is a significant number but not unusually high compared to Pfizer's average trading volume.In recent news, Pfizer has been actively involved in various developments. The company has been working on its COVID-19 vaccine, which has been a major contributor to its revenue. Additionally, Pfizer has been investing in its product pipeline, including several promising candidates that are expected to contribute to...2025-04-2302 minPfizer Industry NewsPfizer's Pandemic Response and Product Pipeline Boost Stock Performance Amid Industry Sustainability EffortsPfizer, one of the world's leading pharmaceutical companies, has been a stalwart in the healthcare industry for decades. As of today, April 17, 2025, the stock price for Pfizer (stock symbol PFE) is $22.12 per share. This price reflects a slight increase from the previous day's closing price of $22.08.The trading volume for Pfizer stock on April 14, 2025, was 61,165,057 shares, which is significantly higher than the average trading volume. This surge in trading activity could be attributed to various factors, including recent news and announcements about the company.One of the most significant recent developments for Pfizer is its continued...2025-04-1702 min
Science Will WinLive from SXSW - How to Leverage Digital Tools to Become an Empowered PatientOver the last five years, the healthcare industry has witnessed an explosive surge in digital health services, revolutionizing the way we access medical care. Patients today are taking charge of their health journey by using different digital tools to stay on top of their preventative screenings, implement dietary and lifestyle changes, access mental health resources, and so much more. In this conversation, patient advocates and industry leaders from Noom, Thrive, and Pfizer, dive into the potential power of artificial intelligence and the anticipated transformation in personalized health plans. They share real-world examples that highlight how digital technologies are helping...2025-04-1659 min
Science Will WinLive from SXSW - Outdoing Cancer Is A Team SportWhile cancer deaths in the United States have declined in recent years, some populations are being left behind—facing complicated challenges to accessing the care they need. Intervening at the earliest stages of disease onset is critical to cancer treatment success and to reducing the risk of recurrence. So how do we create a world where all people with cancer are quickly diagnosed and can live better, longer lives as science advances? In this conversation, patient advocates and healthcare leaders from Pfizer, the American Cancer Society, and the Healthcare Businesswomen’s Association, discuss the power of collaboration in the effo...2025-04-1658 min
Science Will WinLive from SXSW - The Future of Scientific Communications Through PodcastingPodcasting has become essential for communicating breakthroughs in science, offering an accessible and engaging platform to reach diverse audiences. This evolving medium fosters deeper connections by delivering trusted information in accessible and compelling ways. In this conversation, audio makers from Pfizer, Acast, and TED, discuss what it takes to stand out in the science podcast space, insights on strategy, and how they're working to shape the future of health communication.Moderator• Aaron Strout, Former CMO of Real Chemistry and Health PodcasterSpeakers• Erica Santiago, Executive/Digital Communications & Podcast Strategy, Pfizer• Veronika Taylor, SVP of...2025-04-1656 minPfizer Industry NewsPfizer's Positive Trajectory: Decoding the Driving Forces Behind Its Stock PerformanceAs of April 7, 2025, Pfizer's stock price is currently trading at $24.84 USD. This is a slight increase from the previous day's close of $24.70 USD, indicating a positive trend in the short term. The trading volume on April 3, 2025, was 70.46 million shares, which is significantly higher than the average volume, suggesting increased investor interest in the stock.Pfizer has been in the news recently for several significant developments. The company has been making strides in its pipeline productivity, particularly with the successful launch of its cardiovascular drug, Vyndaqel. This drug is seen as a potential game-changer in the rare-disease arena, which...2025-04-0702 minPfizer Industry NewsPfizer's Promising Future: Analysts Predict Steady Growth in 2025 Stock OutlookAs of today, March 28, 2025, Pfizer's stock price is trading at $24.84 USD, with a forecasted range of $22.85 to $26.83 USD for the day. This volatility is typical for Pfizer stock, which has been subject to various market fluctuations over the past year.The trading volume for Pfizer stock has been relatively high, with significant activity observed in recent days. For instance, on January 6, 2025, the stock saw a trading volume of 43,950,971 shares, with a price movement of 1.13 percent. This level of activity suggests that investors are closely monitoring Pfizer's performance, possibly due to the company's diverse portfolio of pharmaceuticals and vaccines.2025-03-2802 minPfizer Industry NewsDiving into Pfizer's Value Proposition: Stable Financials, Promising Oncology Prospects, and Attractive Dividend YieldAs of today, March 24, 2025, Pfizer Inc. (PFE) is trading at $26.46 per share. This price is slightly above the 52-week low of $24.48 but still below the 52-week high of $31.54. The trading volume has been moderate, with recent days averaging around 30 to 40 million shares per day, which is relatively stable compared to the average trading volume.Pfizer has been a focal point for value investors due to its stable financial outlook and compelling valuation. The company projects 2025 revenue between $61 billion and $64 billion, comparable to its 2024 performance of $63.6 billion. This stability, combined with a forward price-to-earnings multiple under 9, significantly lower than...2025-03-2402 min
Science Will WinPart 4 – New Frontiers in AI & Drug DiscoverySo far in this season, we’ve explored how innovations throughout history have brought us to where we are now. We talked about how drug discovery changed from a serendipity-based to data-based endeavor. Then, we explored the powerful hardware and smart software required to accommodate big data. Now, the door to the future of AI in drug discovery is open. In our final episode, we’re looking toward the future, to understand where today’s advancements could potentially take us. Featured Guests:–Charlotte Allerton, Head of Preclinical and Translational Sciences at Pfizer–Daniel Ziemek, Vice President...2025-03-0424 min
Science Will WinPart 3 – How Computers Learn to Think Like ScientistsWith a trove of data and powerful hardware to process it, software is the last element of our artificial intelligence story. In this episode, host Jeremiah Owyang and expert guests explore the history of advancement behind the software that powers AI today. They delve into the creation of neural networks at the heart of this technology and how scientists are partnering with AI to revolutionize the complex process of drug development and discovery. Featured Guests:–Beth Cimini, Associate Director for Bio image Analysis at the Broad Institute in Cambridge, Massachusetts–Charlotte Allerton, Head of Preclinical and...2025-02-2524 min
Science Will WinPart 2 – How Video Games Helped Pave the Way for AI in MedicineLast episode discussed data and how crucial large swaths of data are in assisting drug development. But more data requires a lot of storage – and that’s where hardware comes in. To make use of big data and all its possibilities, scientists need new tools at their disposal. In this episode, host Jeremiah Owyang, alongside expert guests, traces the rise of large-scale computational resources used throughout the medical industry today.Featured Guests:–Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer–Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer–To...2025-02-1823 min
Science Will WinPart 1 – The Data RevolutionThe intersection of biology and technology is revolutionizing drug discovery. In this episode, host Jeremiah Owyang and expert guests explore the crucial role of data in advancing medical science, from the serendipitous discoveries of the past to the cutting-edge techniques of today. They delve into the history of drug development, the rise of "omics," and the innovative single-cell sequencing that is transforming our understanding of the human body for the benefit of drug discovery. Today, scientists are using vast amounts of data to fuel artificial intelligence models, in the quest for new and better medicines. Featured Guests:2025-02-1131 min
Science Will WinComing Soon – Science Will Win, Season 4Artificial intelligence has the potential to help save millions of lives by accelerating the discovery and development of treatments for humanity’s toughest diseases. Those AI innovations come down to three key factors: data, hardware, and software. Science Will Win Season 4 takes listeners on a journey back in time to learn how each of these three elements got where it is today. Each episode features interviews with historians and cutting-edge researchers, framing these deep historical dives within modern advancements in medical technology. What challenges did science have to overcome to bring us where we are today, the midst of an...2025-01-2801 min
PremoniciónPremonición: Episodio 8 - ResistirAbel comprueba que estaba muy equivocado en muchas cosas que daba por sentadas sobre Serén. Está descolocado. Piensa en Valdemar. Piensa en Serén y en el grupo de personas tan resistentes que ha conocido. Tiene que volver a Valdemar antes de que lo echen en falta. O quizá para dar la información a sus jefes. Pero a todo esto, el régimen de Valdemar empieza a atacarles y tienen que tomar decisiones ya.En este capítulo intervienen Mariano Venancio, Jorge Machín, Nikki García, Rocío León, Javier Pascual, Carmen Sánchez, Tino...2024-10-2418 min
PremoniciónPremonición: Episodio 7 - EudaimoníaAbel se lleva una sorpresa inesperada. Los miembros de la resistencia lo ponen en contacto con una persona de Valdemar muy importante para él. No entiende nada. ¿Qué está pasando ahí? Abel acusa a Luz de haber matado a Amir y empieza a temer por su vida.En este capítulo intervienen Mariano Venancio, Jorge Machín, Nikki García, Javier Pascual, Tino Fernández y Carmen Sánchez.
El periodista Abel Uribe llega a la localidad secreta de Serén en busca de información sobre Amir, un líder de la Resistencia frente al rég...2024-10-1712 min
PremoniciónPremonición: Episodio 6 - La revoluciónLuz y Abel vuelven a verse para hablar de Amir Lazly y él le pregunta si es verdad que, como todos creen, tiene pensamientos premonitorios. Mientras tanto, otra mujer de la resistencia, Herzegovina, logra colarse en Valdemar para desarrollar una misión importante relacionada con Abel.En este capítulo intervienen Nikki García, Jorge Machín, Mariano Venancio, Maiken Beitia, Tino Fernández, Javier Pascual, Olga Aguirre, Carmen Sánchez y Maite Hernández
El periodista Abel Uribe llega a la localidad secreta de Serén en busca de información sobre Amir, un líder d...2024-10-1012 min
PremoniciónPremonición: Episodio 5 - Vivir en potenciaEl régimen de Valdemar ha atacado Serén y tienen que pasar la noche en un refugio. A Abel se le está acabando el tiempo y debe regresar a Valdemar. Pero todavía no ha conseguido la información que busca y, en su lugar, descubre que Félix y su padre eran buenos amigos. En Serén todos están impacientes a que Luz mejore de su migraña. Todas las decisiones las consultan con ella porque creen que tiene la capacidad de predecir el futuro.En este capítulo intervienen Nikki García, Carmen Sánchez, Ti...2024-10-0318 min
Future Generations Podcast with Dr. Stanton Hom218: Revealing Pfizer’s Dark Agenda: An Insider Speaks OutIn this episode, Dr. Stanton Hom sits down with Justin Leslie, a former Pfizer scientist turned whistleblower. Justin discusses his unique journey from working on mRNA COVID-19 vaccines at Pfizer to becoming a pivotal whistleblower exposing inconsistencies and alleged fraud within the company. He shares his experiences with Project Veritas, the challenges he faced during his undercover investigative work, and the motivations behind his decision to speak out. Justin also dives into the consequences of mRNA technology, its impact on human health, and the broader implications for society. Furthermore, he highlights his current efforts to share his story through...2024-09-301h 18
PremoniciónPremonición: Episodio 4 - El eterno retornoLuz está abatida en la cama y su hija Clara se acerca para ver si necesita algún cuidado. En el silencio y la oscuridad del dormitorio, Luz recuerda el miedo que tenía de ser madre, por sus crisis de migraña y cómo su médico la animó a que no renunciara a la vida que deseaba. Mientras, Abel y Félix hablan de la racionalidad y la espiritualidad.En este capítulo intervienen Jorge Machín, Nikki García, Tino Fernández, Carmen Sánchez, Olga Aguirre, Dr. Jesús Porta Etessam, Javier Pascual, Maike...2024-09-2614 min
PremoniciónPremonición: Episodio 3 - AtaraxiaFélix, el padre de Luz Nevado, recibe a Abel y le muestra sus recelos por ese pretendido reportaje que va a hacer. Además, le habla del lenguaje que manejan en Serén. ¿Es un código? No. Tiene mucho más que ver con conceptos filosóficos. La conversación se ve interrumpida cuando Clara (su nieta y la hija de Luz) llega para avisarlo de que Luz se encuentra muy mal.En este capítulo intervienen Tino Fernández, Jorge Machín, Olga Aguirre, Carmen Sánchez, Maiken Beitia y Nikki García.
El perio...2024-09-1914 min
PremoniciónPremonición: Episodio 2 - Panta RheiAbel empieza a conocer las incomodidades de Serén y vuelve a quedar con Luz Nevado para que le hable de la resistencia. Luz le explica los motivos por los que abandonó Valdemar y se fue a un lugar con carencias de suministros y muy poca electricidad. Abel también intenta sacar información a la señora del lugar donde se hospeda, Basilia, y ella le dice que en Serén son muy fans de la duda.En este capítulo intervienen Nikki García, Olga Aguirre, Jorge Machín, Mariano Venancio y Javier Pascual.
El p...2024-09-1217 min
PremoniciónPremonición: Episodio 1 - La brevedad de la vidaAño 2040. Un periodista llamado Abel Uribe consigue llegar a la ciudad de Serén. Allí, escondidas, viven cientos de personas contrarias al férreo régimen de Valdemar. Abel quiere que le cuenten cómo era Amir Lazly, el líder de la resistencia, y pretende conocer cómo viven en esa comunidad. La primera entrevista la tiene con Luz Nevado, la mujer que todos ven como la líder de la resistencia.En este capítulo intervienen Jorge Machín, Nikki García, Carmen Sánchez y Rául Escudero.
El periodista Abel Uribe lle...2024-09-1219 min
PremoniciónPremonición - Nuevo episodio cada juevesEl periodista Abel Uribe llega a la localidad secreta de Serén en busca de información sobre Amir, un líder de la Resistencia frente al régimen establecido en Valdemar. ¿Quién era ese hombre al que todos admiraban tanto? ¿Cómo murió? Es el año 2040, pero en Serén apenas hay electricidad y les faltan muchos productos básicos. Abel conoce a Luz, una mujer a la que todos consideran la guía de esta comunidad, aunque ella no se siente así. Ella huyó a Serén escapando del régimen de Valdemar...2024-09-0901 min
Global ValueIs Pfizer Stock a Buy Now!? | PFE Stock Analysis! |In this video, we'll perform a PFE stock analysis and figure out what Pfizer looks like based on the numbers. Is Pfizer stock a buy?
🚨 Start a 7-Day Free Trial Now https://www.patreon.com/GlobalValue
We'll also try to figure out what a reasonable fair intrinsic value is for Pfizer. And answer is Pfizer one of the best stocks to buy at the current price? Find out in the video above! Global Value's Pfizer stock analysis.
Thank you for watching. ❤️ Please support the channel by checking out our affiliates. All commissions are reinvested to improve the quality of videos...2024-07-1011 min
The DailyClout NetworkUnstoppable with Amy Kelly: "Pfizer/FDA Knew in Early 2021 That Pfizer mRNA Injection Caused Dire Fetal and Infant Risks"Amy Kelly, DailyClout’s COO and Project Director for the War Room/DailyClout Pfizer and Moderna Documents Analysis Project, explains the key findings in Report 69, a bombshell report showing that Pfizer and the FDA knew in early 2021 that the Pfizer mRNA COVID “vaccine” caused dire fetal and infant risks, including death. They began an aggressive campaign to vaccinate pregnant women anyway. Some of the key findings can be found below.* The FDA released Pfizer's eight-page “Pregnancy and Lactation Cumulative Review.” in the April 2023 court-ordered document production.* The data in the “Cumulative Review” span “…from the time of drug produ...2024-05-1610 min
Science Will WinLive from SXSW - Moonshot Culture: Innovating to Outdo YesterdayThroughout history, humans have coalesced around moonshot culture to achieve audacious goals—from eradicating smallpox, to sequencing the human genome, to landing a spacecraft on Mars. These feats of human ingenuity didn’t happen in a vacuum, they were born from intentional innovation, a “coalition of the willing,” and a vision to outdo yesterday. This fireside chat with Drew Panayiotou, Former CMO of Pfizer and Devon Still, ex-NFL player and founder of Still Strong Foundation, explores innovations in cancer, their personal experiences with family members needing healthcare treatment, and what it will take to achieve Pfizer's next big moonshot to outdo...2024-04-1849 minScience Will WinLive from SXSW - Scientific Storytelling: The Audio AdvantagePodcasting has exploded in the last 5 years, with every celebrity, brand, and influencer investing in audio. It’s estimated that 144MM people in the U.S. listen to a podcast monthly. With scale and an ability to build audience connections, podcasts have become effective at communicating complex information in a digestible way–making them perfect for sharing science-based stories. Many have heard the term "gene therapy," but how many know what it means? How do you explain the science behind artificial intelligence or designing the Mars Rover? Audio allows us to do this, while enhancing the impact of science comm...2024-04-1852 minScience Will WinLive from SXSW - The Future of CancerIn a live taping of the Science Will Win podcast, Host and Artificial Intelligence Expert Jeremiah Owyang speaks to cutting-edge healthcare leaders about the impact that AI is having on the future of cancer. Thirty years ago, the thought of a world without cancer was nothing more than a dream. Similarly, AI was considered a technology that had yet to become reality. Today, we are reimagining a future where the AI revolution will help change the trajectory of cancer as we know it.Featured experts:Edward Cox, Head & General Manager Of Digital Health & Medicines, PfizerJulie Gerberding...2024-04-1843 min
Earn Your LeisureThe Future of Pfizer: Analyzing the Pharmaceutical Industry WarsJoin Rashad Bilal, Ian Dunlap, and Troy Millings in this thought-provoking episode as they dive into the uncertain future of Pfizer in the pharmaceutical industry. As the hosts candidly discuss the current state of Pfizer and its potential recovery, viewers gain valuable insights into the factors influencing the company's trajectory.In this episode, the EYL team dissects Pfizer's challenges, including its management decisions, debt burden, and loss of exclusive rights to blockbuster drugs. The impact of the pandemic and missed opportunities in the weight loss drug market are also examined. With a shift in...2023-12-3008 min
Women's Healthmenopause: unmuted: Menopause in the workplaceIt’s time to talk about menopause in the workplace. In this final episode of the season, Dr. Mary Jane Minkin welcomes guests Barbara Brooks (founder of SecondActWomen) and Dr. Nikki Shaffer (Head of Colleague Wellness at Pfizer) for an in-depth discussion on the topic of menopause in the workplace. The ladies bring their expertise and life experience to reflect on common challenges and opportunities that women may face in their careers. The conversation touches on: navigating age stigma and burnout, managing menopause symptoms during the workday, shifting priorities, changing careers, and more.Disclaimer: menopause: unmuted is desi...2023-12-2037 minGlobal ValueIs Pfizer Stock a Buy Now!? | Pfizer (PFE) Stock Analysis! |In this video, we'll perform a PFE stock analysis and figure out what Pfizer looks like based on the numbers. We'll also try to figure out what a reasonable fair intrinsic value is for Pfizer. And answer is Pfizer one of the best stocks to buy at the current price? Find out in the video above! Global Value's Pfizer stock analysis.
TIKR is the website I use for financial data in my videos. Join me and thousands of investors worldwide by using TIKR in your investment analysis. All funds from referrals directly support the channel to improve video quality!
...2023-12-0715 minScience Will WinPart 4 – Using AI to Get One Step Ahead of Antibiotic ResistanceIs it possible to live in a world without antibiotic resistant bacteria? For the final episode of this season, we’re looking ahead to the future and getting a glimpse of a potential world in which we stay one step ahead of AMR, and what is helping us get there. Host Jeremiah Owyang and expert guests will talk about the education, surveillance, and policy efforts needed for success in the fight against antibiotic resistant bacteria. And we’ll explore how artificial intelligence can empower us in those efforts — and enable more effective, accessible, and equitable healthcare.Featured Guests...2023-12-0531 minScience Will WinPart 3 – AI in the Lab: Accelerating Antibiotic DiscoveryArtificial intelligence has the power to transform the way researchers study bacteria and develop new treatments – and we’re already seeing the benefits in healthcare. In part three, host Jeremiah Owyang and expert guests shed light on how AI expedites and enhances analyses, revolutionizing the search for new antibiotics. The benefits of AI extend to analyzing bacterial DNA, uncovering vulnerabilities, and potentially predicting bacterial evolution. This innovative technology aids scientists in pinpointing the most promising antibiotic candidates from a sea of possibilities and helps to streamline drug development.Featured Guests:Adrian Egli, Director, Institute of Medical Micr...2023-11-2826 minScience Will WinPart 2 – The Power of Data and Artificial IntelligenceArtificial intelligence could be an essential tool in the fight against antibiotic resistant bacteria – and data is a key part of developing that tool. In part two of this four-part series, expert guests break down the mechanics behind artificial intelligence and machine learning. As host Jeremiah Owyang traces the evolution of these tools in healthcare, he highlights the crucial role of data for understanding the problem of antibiotic resistance. Featured Guests:Adrian Egli, Director, Institute of Medical Microbiology, University of ZurichRanjit Kumble, Vice President of Enterprise Data Science and Advanced Analytics, PfizerMarinka Zitnik, Assistant Professor, Department of...2023-11-2130 minScience Will WinPart 1 – The Battle Against Antibiotic ResistanceMedicine’s struggle with antibiotic resistant bacteria is reaching a crisis point. In part one of this four-part series, host Jeremiah Owyang and expert guests delve into the world of antibiotics, exploring their history, the rise of antibiotic resistance, and the story of a patient whose life was forever changed by antibiotic-resistant bacteria. They break down the critical issues at stake and discuss the multifaceted solutions needed to combat this pressing crisis – including artificial intelligence.Featured Guests:Adrian Egli, Director, Institute of Medical Microbiology, University of ZurichJay Purdy, Vice President and Therapeutic Area Lead, Global Medical Affa...2023-11-1527 minScience Will WinComing Soon – Science Will Win, Season 3Since antibiotics were first discovered, bacteria have been evolving to outsmart them. But today, the latest science is rising up to meet the challenge. This season of Science Will Win is exploring how artificial intelligence (AI) can help the scientific community overcome one of the greatest challenges facing humanity: antimicrobial resistance. This season, we’ll hear from researchers, doctors, patients, patient advocates, computer scientists, and AI experts. All of them are on the cutting edge of the fight against antimicrobial resistance. Tune in to this new, four-part series, coming soon!Season 3 of Science Will Win is created by...2023-11-0704 minGlobal ValueIs Pfizer Stock a Buy Now!? | Pfizer (PFE) Stock Analysis! |In this video, we'll perform a PFE stock analysis and figure out what Pfizer looks like based on the numbers. We'll also try to figure out what a reasonable fair intrinsic value is for Pfizer. And answer is Pfizer one of the best stocks to buy at the current price? Find out in the video above! Global Value's Pfizer stock analysis.
TIKR is the website I use for all financial data in my videos. Join me and thousands of investors worldwide by using TIKR to supercharge your investment analysis. All funds from referrals directly support the channel to improve...2023-08-2010 min
Charles² – Pharma InsightsKooperationen: Warum sie wichtig sind und wie sie funktionierenIn dieser Folge geht es um Kooperationen. Wir sprechen darüber, welche Bedeutung sie beim medizinischen Fortschritt der Zukunft haben. Und darüber, was eine gute, was eine schlechte Kooperation ausmacht. Unsere Gäste sind allesamt kooperationserfahren. Dr. Birgit Kerber, Head of Innovation and Translation EMBL-EBI bei EMBLEM, einem auf Technologietransfer spezialisierten Unternehmen mit Sitz in Heidelberg sowie die Biochemikerin Dr. Anette Sommer und ihr Kollege, der Immunologe Dr. Ulrich Zügel, beide bei Pfizer. Für beide ist Kooperation der bedeutende Teil ihres Berufes. Denn sie suchen von Berlin aus für Pfizer in ganz Europa sowie Israel nach vi...2023-02-1341 min
Forever JungPROJECT VERITAS. JORDON TRISHTON WALKER RIVELA SEGRETI DI PFIZER, CREAZIONE VARIANTI VIRUS E ALTRO, 26-01-2023🔴💣BOMBA NUCLEARE E STORICA! IL VIDEO ORIGINALE DI PROJECT VERITAS RISALE AL 26/01/2023.
🔥I GIORNALISTI D'ASSALTO DI 'PROJECT VERITAS' COMBINANO UN APPUNTAMENTO 'GALANTE' FRA JORDON TRISHTON WALKER, DIRETTORE DI RICERCA E SVILUPPO PER LE OPERAZIONI STRATEGICHE E I PIANI SCIENTIFICI MRNA DI PFIZER ED UN LORO GIORNALISTA SOTTO COPERTURA.
✴️WALKER SI SBOTTONA E RACCONTA SEGRETI PAZZESCHI DELLA SPIETATA MULTINAZIONALE FARMACEUTICA.
🏴☠️È LA STESSA PFIZER CHE, ATTRAVERSO WALKER AVEVA APPENA RIVELATO CHE LA PFIZER, ATTRAVERSO L’EVOLUZIONE DIRETTA (VARIANTE DEL "GUADAGNO DI FUNZIONE", DEFINITO COME “UNA MUTAZIONE CHE CONFERISCE UNA NUOVA O MAGGIORE ATTIVITÀ A UNA PROTEINA”), INGENERAVA VIRUS POTENZIATI PER VENDERE VACCINI...2023-02-0300 min
DarkHorse Podcast#159: Monkey Business at Pfizer (Bret Weinstein & Heather Heying DarkHorse Livestream)In this 159th in a series of live discussions with Bret Weinstein and Heather Heying (both PhDs in Biology), we discuss the state of the world through an evolutionary lens. This week, we discuss how to predict things that reliably turn out to be true, especially in the public health sphere: use the scientific method, employ a generalist toolkit, and engage in campfire conversations. We also talk about the Project Veritas video of a Pfizer executive discussing what Pfizer may be discussing, Pfizer’s official response to that video, and what the implications are societally and...2023-01-291h 54
The AntigenThe Road Ahead: From Maternal Vaccine Development to AdministrationProtection from serious infant illnesses isn’t enough. Helping prevent the disease from happening altogether is the goal of physician-scientists, like Dr. Bill Gruber. As the Senior Vice President of Pfizer Vaccine Clinical Research and Development, Bill explains how maternal vaccinations are developed, the inequities in this process, and the importance of clinical trial participants. This final episode concludes with the real life-changing impact of maternal immunization.Special thanks to the maternal immunization team at Pfizer. The Antigen is produced by Wonder Media Network.
2022-12-0622 minThe AntigenMaternal Vaccines: Breaking Barriers and Finding SolutionsWhat stands in the way of pregnant people getting vaccination shots? Part two of our maternal immunization mini-series answers this question and more. Host Kari Yacisin talks with Dr. Fauzia Malik, an associate research scientist at the Yale School of Public Health, about the barriers to widespread maternal immunization and the solutions to those challenges. We’re covering everything from the truth about vaccine hesitancy, the role of healthcare providers, and who and where we can look to for guidance as we work to increase uptake.Special thanks to the maternal immunization team at Pfizer and the pr...2022-11-2920 min
Charles² – Pharma InsightsStille Pandemie: Wie können wir Antibiotikaresistenzen besser begegnen?Mehr als 1,2 Millionen Tote jährlich - laut der Weltgesundheitsorganisation (WHO) stellen antimikrobielle Resistenzen eine der zehn größten Gefahren für die öffentliche Gesundheit dar. Wir sprechen darüber, wie Antibiotikaresistenzen entstehen, welche Bedeutung sie im klinischen Alltag eines großen Klinikums haben, wie Menschen behandelt werden, die betroffen sind, und welche Strategien verfolgt werden, um diesen Resistenzen zu begegnen. Die Gäste in dieser Folge sind PD Dr. Irit Nachtigall, Anästhesistin und Intensivmedizinerin und Regionalleiterin Infektiologie und ABS, sowie Fachgruppenleiterin Infektiologie bei den Helios Kliniken. Und Caroline Schweizer, Senior Medical Advisor im Bereich Antiinfektiva bei Pfizer.
2022-11-1836 minThe AntigenMaternal Immunization 101In the first episode of this three-part series, host Kari Yacisin introduces us to the world of maternal immunization. Vaccinations for pregnant people are not new, but they have historically been left out of the vaccine narrative. With the help of expert Beate Kampmann, pediatric infectious disease specialist, Kari walks us through the importance of maternal immunization, its history, and what it really means to transfer protection from mother to child.Special thanks to the maternal immunization team at Pfizer and the production team at Wonder Media Network.
2022-11-1519 minThe AntigenIntroducing The Antigen Season 3: Maternal ImmunizationThe Antigen returns with a three-part mini-series spotlighting maternal immunization. When it comes to vaccine development, there is a shifting paradigm – help protect pregnant women and their infants through research rather than from research. As maternal immunization is advancing vaccine science and innovation, this series delves into the history of maternal immunization, the potential benefits of boosting infant immunity, and the role of maternal antibodies in helping protect infants. We’ll also explore the challenges of maternal immunization and what the future holds. Listeners will hear from three experts who are making significant contributions to the field.This...2022-11-0102 min
Science Will WinPart 1: Breast Cancer: The Science, The Challenges, The SolutionsOncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer.Featured Guests:Martha Carlson, Breast Cancer Advocate & WriterDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJeff Settleman, Chief Scientific Officer, Pfizer Oncology
2022-10-2730 min
Science Will WinPart 2: Clinical Trials: Bringing Research to LifeIn part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials?Featured Guests:Laurie, Breast Cancer Clinical Trial ParticipantDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJulia Perkins Smith, Global Clinical Lead, PfizerJamil Rivers, CEO, Chrysalis InitiativeAdditional Resources:pfizerclinicaltrials...2022-10-2729 min
Women's Healthmenopause: unmuted: Mary Beth's StoryE2: Mary Beth’s StoryIn this episode, Mary Beth reflects on how family attitudes and her experiences growing up and going through puberty have impacted her own mid-life journey. Mary Beth discusses the defining symptoms of her menopause (heavy periods, and bone loss) and how they led her to change her career, becoming a yoga teacher and nutritional coach to help other women with osteopenia and osteoporosis. “The women in my practice will often report to me that they had no idea that their bones were going to be affected by menopause. I think that...2022-07-2127 min
Women's Healthmenopause: unmuted: Marilyn's StoryE1: Marilyn’s StoryIn this episode, Marilyn’s story explores the power of family relationships and self-care in supporting a positive menopause. Marilyn shares her experiences of how open communication within her family de-mystified menstruation and menopause right from the time of puberty. Conversations with her female relatives gave her strength and guided her to approach perimenopause, along with overall wellbeing and self-care, with a positive attitude. Remember, menopause is a new phase of life: you haven’t been there before, so isn’t it great to have trusted family and friends who can share wit...2022-07-0725 min
Frictionless MarketingPFIZER’s Sally Susman on Adaptability and Taking the Leap into Social Media with Pharma“There have been times when my team has proposed something, and I say, ‘Let's do it,’ and then we get blow-back very swiftly. Do you know what we do? We take it down, and we move on. You can't succeed in this realm if you're not willing to fail in this realm.”Sally Susman is the EVP & Chief Corporate Affairs Officer at Pfizer, U.S., where she leads engagement with all of Pfizer’s external stakeholders overseeing Communications, Corporate Responsibility, Global Policy, Government Relations, Investor Relations, and Patient Advocacy. She also serves as Vice Chair of The Pfizer Fou...2022-01-2032 min
Science Will WinBONUS – Into the Pfizer Lab: Making a Gene TherapyIn this special bonus episode, Adam Rutherford explores a different aspect of gene therapy - how do you actually make one? Expert guests discuss the highly complex task of scaling-up manufacturing from the small amounts needed for research, to creating batches big enough for clinical and commercial scale. And once that hurdle has been cleared, how do they address the additional challenge of storing and transporting the medicine at ultra-low temperatures?Featuring guests:Bert Bruce, Regional President, North America, Rare Disease, PfizerBob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Pfizer Son...2021-12-1014 min
Charles² – Pharma InsightsWie die Digitalisierung zum medizinischen Fortschritt beiträgtMit der elektronischen Patientenakte (ePA) und der Digitalisierung kommen auf das Gesundheitswesen neue Herausforderungen, aber auch neue Chancen zu. Aktuell spielen Krankenkassendaten in der Versorgung eine große Rolle und auch Register, wie die vorherige Podcast-Folge (Wie Daten aus der Versorgung die Medizin verbessern können) genauer erläutert hat. Nicht zuletzt Informationslücken im Rahmen der Corona-Pandemie haben aufgezeigt, dass für viele Fragen nicht genügend Daten zur Verfügung standen, um Antworten zu geben. Kathrin Klär-Arlt, Leiterin Politik & Public Affairs, Informatiker Dr. Daniel Ziemek, der von Deutschland aus für die weltweite Forschungs- und Entwicklungsabteilung von Pfize...2021-11-2523 minCharles² – Pharma InsightsWie Daten aus der Versorgung die Medizin verbessern könnenMit klinischen Studien weisen pharmazeutische Hersteller die Wirksamkeit und die Verträglichkeit neuer Medikamente nach. Erst auf Basis einer umfassenden klinischen Prüfung kann eine Zulassung beantragt werden. Als Ergänzung zu den Erkenntnissen aus den klinischen Studien können Daten von Krankenkassen, aus Krankenhäusern und Praxen wertvolle Informationen liefern. Voraussetzung allerdings ist bei sogenannten Real World Data (RWD), dass sie richtig erhoben und geteilt werden. Zu den Quellen von Daten aus dem Versorgungsalltag zählen Abrechnungsdaten, die von den Krankenkassen erfasst werden, und Register. Welche Arten von Registern es gibt, erläutert Kinderärztin Dr. Tatjana Gabbert, die an v...2021-11-1823 minCharles² – Pharma InsightsWas Arzneimittel kosten dürfenIn Deutschland soll sich der Preis eines Medikaments an dem Nutzen orientieren, den es bringt. Messbar kann ein Nutzen dann werden, wenn man – z. B. in einer Bewertungsmatrix – Kriterien definiert und gewichtet. Doch wie lässt sich etwas so Individuelles wie der Nutzen einer Therapie für Patient:innen messen? Die erste Folge der zweiten Staffel von Charles² – Pharma Insights beleuchtet, wie Arzneimittelpreise entstehen, welche Vorteile das Arzneimittelmarktneuordnungsgesetzes (AMNOG) für Patient:innen bringt und an welchen Stellen das System an seine Grenzen gerät. Auf welcher Grundlage Preise für Arzneimittel in Deutschland verhandelt werden, erläutern Verhandlungsführerin Dr. Mel...2021-11-1126 minCharles² – Pharma InsightsWie der erste mRNA-Impfstoff entstandDas Ergebnis ist allgemein bekannt: Ende des Jahres 2020 erhielt in der Europäischen Union erstmals ein auf der neuartigen mRNA-Technologie basierender Impfstoff eine bedingte Zulassung. Den Ausgangspunkt für die erfolgreiche transatlantische Kooperation gegen COVID-19 – die mRNA-Plattform – hatte das deutsche Unternehmen BioNTech entwickelt. Pfizer wiederum brachte die Expertise ein, den vielversprechendsten Impfstoffkandidaten schnellstens zu ermitteln und zu entwickeln, zur Marktreife zu bringen und verfügbar zu machen. Was in Bewegung gesetzt werden musste, um innerhalb kürzester Zeit mehr als 40.000 Menschen in klinische Studien einzuschließen, schildert Dr. Kathrin Jansen (auf Englisch). Sie leitet die Erforschung und Entwicklung neuer Impfstoff...2021-11-0418 min
Science Will WinWhat’s Next For Gene Therapy?Gene therapy is at a pivotal moment. For eligible rare disease patients, the potential impact could be huge. So how can we support that potential to fruition and what will it mean if we do? In our season finale, host Adam Rutherford and guests take a peek into what a world with successful gene therapies could look like for patients, healthcare and society.Featuring guests:Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare DisordersErik Paulsen, Chair, Institute for Gene TherapiesKarolina Hanslik, Former Senior Project Manager, EURORDISNikhil Gadre, Senior Director...2021-10-2931 min
Science Will WinThe Policy PuzzleAs with any new breakthrough medicine, entering the healthcare system comes with a host of obstacles and potential barriers. In this episode, Adam Rutherford and guests break down the big changes needed within the global healthcare ecosystem to ensure that, once approved, the therapies we’re researching now, like gene therapy, reach the patients who need them.Featuring guests:Bert Bruce, Regional President, North America, Rare Disease, Pfizer Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, PfizerDurhane Wong-Rieger, President & CEO at Canadian Organization for Rare DisordersEmily Crossley, Chief Executive Offi...2021-10-2228 min
Science Will WinClinical Trials: Courage and PerseveranceGene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients.Featuring guests:Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, PfizerEmily Crossley, Chief Executive Officer, Duchenne UKErik Paulsen, Chair, Institute for Gene TherapiesProfessor John Rasko, Clinical Haematologist & Trial Investigator, University of SydneySimone Boselli, Director, Public Affairs, EURORDIS2021-10-1526 min
Science Will WinGene Therapy – Behind the ScienceGene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us through the history, science, and significance of gene therapy.Featuring guests:Dirk Vander Mijnsbrugge, Vice President, Medical Affairs, Rare Diseases, PfizerDurhane Wong-Rieger, President & CEO at Canadian Organization for Rare DisordersLaurence Woollard, Director, On The Pulse ConsultancySonal Bhatia, Chief Medical Officer...2021-10-0825 min
The Daily CafeThe FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID*The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID*La FDA aprueba Pfizer-BioNTech Booster para personas mayores de 65 años o con alto riesgo de COVID severoThe Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine for people 65 and older and others at high risk of severe COVID-19.La Administración de Alimentos y Medicamentos autorizó el miércoles una dosis de refuerzo de la vacuna Pfizer-BioNTech COVID-19 para personas de 65 años o más y otras personas con alto riesgo de COVID-19 grave.2021-09-2305 min
KenFM: TagesdosisIllegale Geheimverträge des Impfherstellers Pfizer mit Nationalstaaten | Von Hermann PloppaUngleicher Tausch: Pfizer sahnt die Gewinne ab – die Steuerzahler haben keine Rechte und müssen für alle Schäden selber aufkommen.Ein Kommentar von Hermann Ploppa. Ende letzten Jahres sagte RKI-Chef Lothar Wieler schier unglaubliches in einem TV-Interview: „Also, wir gehen alle davon aus, dass im nächsten Jahr Impfstoffe zugelassen werden. Wir wissen nicht genau, wie die wirken. Wie gut die wirken. Was die bewirken. Aber ich bin sehr optimistisch, dass es Impfstoffe gibt.“ (1) Wir werden also mit massivem Erpressungsdruck dazu gebracht, uns eine Substanz einzuverleiben, über deren Wirkungsweise und Schadenspotential bis jetzt nichts bekannt ist. Das ist vom medizin...2021-08-2112 minCharles² – Pharma InsightsNach der Markteinführung neuer MedikamenteWird ein neues Medikament oder ein Impfstoff nach der Zulassung auf den Markt gebracht, regelt das Heilmittelwerbegesetz (HWG), wen und wie die Hersteller der Arzneimittel darüber informieren dürfen. Direkt an Patientinnen und Patienten dürfen sich Informationen zu verschreibungspflichtigen Arzneimitteln über die Gebrauchsinformation hinaus dabei nicht wenden. Wird in Deutschland ein neues verschreibungspflichtiges Arzneimittel auf den Markt gebracht, richtet sich die Kommunikation daher an medizinische Fachkreise. Was darunter zu verstehen ist und wie eine solche Kommunikation erfolgt, schildern in Folge 6 von „Charles² – Pharma Insights“ Juristin Nicole von Gregory, Marketing-Verantwortliche Sirkka Meier und Dr. Daniel Kalanovic, Arzt und medizinisch...2021-07-0822 minCharles² – Pharma InsightsWie die Tablette in die Apotheke kommtUm Patientinnen und Patienten über Apotheken, Kliniken und Praxen in Deutschland täglich mit den benötigten Medikamenten und Impfstoffen versorgen zu können, sind eine ausgeklügelte Logistik und der Pharma-Großhandel nötig. In Folge 5 von „Charles² – Pharma Insights“ spricht Thomas Kiekenbeck, der als stellvertretender Großhandelsbeauftragter dafür sorgt, dass der Handel entsprechend den gesetzlichen Regularien durchgeführt und aufrechterhalten wird. Ebenfalls zu hören ist Patric Schulz, der den Pfizer-Standort Karlsruhe mit dem dort betriebenen Distributionszentrum und der Logistik leitet. Als weitere Gesprächspartnerin ist Dr. Alexa Winter dabei, die als Leiterin der Abteilung Fertigwarenkontrolle mit ihrem Team die...2021-07-0119 min
Women's Healthmenopause: unmuted: Speak UpThe final episode of Season 2 brings different healthcare professional perspectives on menopause. Series host, Dr Mary Jane Minkin, is joined by women's health nurse practitioner, Dr Shelagh Larson, and behavioural psychologist, Dr Sheryl Kingsberg. In a lively conversation, the three women’s health experts delve deeper into the breadth of symptoms and experiences shared by the women in Season 2, normalizing and contextualizing all the while encouraging women to speak up about their symptoms. menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or rec...2021-06-3025 minCharles² – Pharma InsightsAuf welcher Basis Zulassungsbehörden entscheidenDamit neue Medikamente oder neue Impfstoffe in Deutschland verordnet werden können, ist eine Zulassung nötig. In der Regel reichen pharmazeutische Unternehmen dazu ein Antrag bei der Europäischen Arzneimittelagentur (EMA) ein. Wie man sich das vorstellen kann und welche verschiedenen Zulassungsverfahren es gibt, berichten in Folge 4 von „Charles² – Pharma Insights“ Dr. Anneke Hackling und Dr. Georg Lang. Sie und ihre Teams bei Pfizer stehen in ihrem Arbeitsalltag mit der EMA, aber auch den deutschen Bundesoberbehörden wie dem Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) sowie dem Paul-Ehrlich-Institut (PEI) regelmäßig in Kontakt. Weitere Informationen gibt es unter www.pfiz...2021-06-2427 minCharles² – Pharma InsightsWas in klinischen Studien geschiehtNeue Arzneimittel und Impfstoffe werden zunächst im Labor und dann an Tieren überprüft. Ob sie Menschen wirklich helfen und auch verträglich sind, können erst Untersuchungen an freiwilligen Personen belegen. In Folge 3 von „Charles² – Pharma Insights“ erläutert der Arzt Dr. Gereon Zöllner, warum die Teilnahme an einer klinischen Prüfung immer auch ein wichtiger gesellschaftlicher Beitrag ist. Die Biochemikerin und Virologin Dr. Carolin Guenzel zeigt auf, warum es für die eigene Gesundheit Vorteile bringen kann, an einer klinischen Studie teilzunehmen. Und Dr. Daniel Kalanovic, Arzt und medizinischer Leiter bei Pfizer in Deutschland, schildert, warum man sicher...2021-06-1726 min
Women's Healthmenopause: unmuted: Carla's StoryFrom working out five days a week to not wanting to go to the gym at all, fitness devotee Carla talks about how she “had to figure out a way of getting back” from the low mood and loss of energy she experienced in menopause, and how setting realistic goals helped her find her way back to feeling her ‘fab ‘n’ fit’ self.menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Linkshttps://www.menopauseunmuted.comhttps://ww...2021-06-1621 minCharles² – Pharma InsightsWie aus einem Wirkstoff eine Tablette wirdBei der Entwicklung neuer Arzneimittel gibt es einiges zu beachten, damit sie einen Wirkstoff genau dahin bringen, wo er wirken soll. Sogenannte Hilfsstoffe geben einer Tablette die nötige Größe und Stabilität, steuern aber auch, wann und wie der Wirkstoff im Körper freigesetzt wird. In Folge 2 von „Charles² – Pharma Insights“ sprechen Dr. Clemens Stief, der die Entwicklung neuer Tabletten und Kapseln am Produktionsstandort Freiburg leitet, und Dr. Meike Vanhooren, die mit ihrem Team auf globaler Ebene Zulassungsbehörden über Entwicklungsprojekte informiert. Sie erläutern, was geschehen muss, damit eine neue Therapie schnell zu jenen Menschen kommen kann, für die a...2021-06-1023 min
Women's Healthmenopause: unmuted: Catherine's StoryIn her own words, Catherine “crashed into menopause.” It made her feel off-balance both physically and emotionally. Candidly, she describes the hot flashes, night sweats, and skin changes that characterized her menopause and why she feels a responsibility to talk about it. Catherine Is the founder of a global online community of midlife women and believes “it’s really important for women to share stories.” menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Linkshttps://www...2021-06-0921 minCharles² – Pharma InsightsWie neue Wirkstoffe entdeckt werdenFür die Entwicklung neuer Medikamente ist es entscheidend, die Biologie und die Mechanismen von Krankheiten zu verstehen. Kennt man die Zielstrukturen, kommen riesige Substanz-Bibliotheken und bioinformatische Modelle zum Einsatz, um passende Wirkstoffkandidaten zu ermitteln und danach im Labor auszutesten. Das geschieht bei Pfizer in den USA. Aber auch Kooperationen mit externen Forscher:innen sorgen für wissenschaftliche Durchbrüche. In Folge 1 von „Charles² – Pharma Insights“ schildern Dr. Daniel Kalanovic, Arzt und medizinischer Leiter bei Pfizer in Deutschland, und Dr. Uwe Schönbeck, der bei Pfizer auf globaler Ebene die Zusammenarbeit mit externen Partnern verantwortet, wie neue Wirkstoffe entdeckt werden. Wei...2021-06-0320 min
Women's Healthmenopause: unmuted: Chenoa's StoryChenoa describes herself as an emotional and soul intelligence expert. She considers her menopause journey as a powerfully positive time of renewal to “create the things that work for me.” In her episode she speaks honestly about the effect her menopause had on sex and intimacy, and how open discussion with her husband helped her move into this next stage in her life with confidence.menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Links.https://www.m...2021-06-0220 minCharles² – Pharma InsightsWelche Einblicke Charles² in die Pharmabranche bietetIn „Charles² – Pharma Insights“ erläutern Pfizer-Expert:innen, wie neue Medikamente und Impfstoffe entwickelt und verfügbar gemacht werden. Was die Hörer:innen erwartet und wofür der Name steht, erklärt Susanne Straetmans, Leiterin der externen Kommunikation bei Pfizer in Deutschland. Moderiert wird der Podcast von Kommunikationsmanagerin Dr. Anke Kugelstadt. Weitere Informationen zur ersten Staffel und den Folgen gibt es unter www.pfizer.de/podcast-charles2.
2021-06-0101 min
Women's Healthmenopause: unmuted: Shauna's StoryFashionista and midlife social media influencer, Shauna describes the intense hot flashes and uncontrollable periods that defined her menopause journey. She explains how her doctor “helped me realise what was going on in my body.” She challenges women not to fear menopause, but to talk about it and embrace it.menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Links https://menopauseunmuted.com/https://www.pfizer.com/health-wellness/diseases-conditions/menopause
2021-05-1221 min
Coronavirus - BastaBugie.itLa Pfizer le frodi sanitarie e il vaccino contro il coronavirusTESTO DELL'ARTICOLO ➜http://www.bastabugie.it/it/articoli.php?id=6405LA PFIZER, LE FRODI SANITARIE E IL VACCINO CONTRO IL CORONAVIRUSI tempi per il vaccino anti-Covid sono stati estremamente accelerati... ma è giusto che sia la popolazione a fare da cavia? (VIDEO: Inventori di malattie, con una intervista all'ex vicepresidente del settore marketing della Pfizer)da WikipediaPfizer Inc. è un'azienda farmaceutica statunitense. È la più grande società del mondo operante nel settore della ricerca, della produzione e della commercializzazione di farmaci. [...]La Pfizer vanta la più grande organizzazione di ricerca e sviluppo dell'industria farmaceutica grazie alla sua...2020-12-1613 min
Biotech 2050 Podcast24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOneJoyL is the General Manager of Pfizer CentreOne, a global contract development and manufacturing organization (CDMO) and a leading supplier of specialty APIs embedded within Pfizer. In 2019, under her leadership, Pfizer CentreOne contributed $810M in revenue with a growth rate of 9% while advancing Pfizer’s purpose of delivering breakthroughs that change patients’ lives. In 2020 Pfizer CentreOne received the Life Science Leader and Outsourced Pharma CMO Leadership Award for the fourth consecutive year, recognizing the strong partnerships built with customers.
JoyL began her 20+ year career at Pfizer as a healthcare representative and progressed through a series of sales, operational, and strategic lead...2020-07-2921 min
Biotech2050 Podcast24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOneJoyL is the General Manager of Pfizer CentreOne, a global contract development and manufacturing organization (CDMO) and a leading supplier of specialty APIs embedded within Pfizer. In 2019, under her leadership, Pfizer CentreOne contributed $810M in revenue with a growth rate of 9% while advancing Pfizer’s purpose of delivering breakthroughs that change patients’ lives. In 2020 Pfizer CentreOne received the Life Science Leader and Outsourced Pharma CMO Leadership Award for the fourth consecutive year, recognizing the strong partnerships built with customers.
JoyL began her 20+ year career at Pfizer as a healthcare representative and progressed through a series of sales, oper...2020-07-2920 minThe Antigen#COVID19: Teamwork Makes the Dream WorkIn the last episode of The Antigen’s #COVID19 mini-series, we examine the teamwork & collaboration across communities in the fight against coronavirus. How are companies working together to develop potential vaccines for COVID-19? How has the global health community at large been helpful in responding to the pandemic?Host Lindsey Dietschi speaks with two guests — Elsie Soto, Vice President of Emerging Markets for Pfizer’s Global Supply & Dr. Frank Mahoney, Senior Immunization Officer at the International Federation of Red Cross and Red Crescent Societies (IFRC).For the latest updates, visit pfizer.com/coronavirus.
2020-06-3026 minThe Antigen#COVID19: The Quest for a VaccineWhat does finding a vaccine actually look like? Who’s involved? Last season on The Antigen we outlined the many steps it takes for a vaccine to go from discovery to distribution, in this episode we ask if that process can safely accelerate for COVID-19. We’ll also wrap up with the latest headlines on Pfizer's response to the crisis.Host Lindsey Dietschi speaks with Phil Dormitzer, Vice President and Chief Scientific Officer of Viral Vaccines at Pfizer.Episode references:Pfizer Partners with Direct Relief to Provide Critical COVID-19 Supplies to HospitalsPfizer, BioNTech to ramp...2020-06-1625 minThe Antigen#COVID19: What Do We Do in the Meantime?In this episode, we talk about what public health experts are focused on now to help minimize the impact of COVID-19. We’ll cover how routine health programs are being impacted and what is being done to plan for recovery. And we’ll discuss what we can do now that's working & what we can improve. Host Lindsey Dietschi speaks with Shanelle Hall, Founder Member of The Yellow House & AI Advisory Council Member for the World Economic Forum. Prior to her current roles, she worked at UNICEF for over 20 years, most recently as the Assistant Secretary General.Epis...2020-06-0222 minThe Antigen#COVID19: Looking Back to Look ForwardThe Antigen is back with a special mini-series focused on COVID-19. In this first episode, we’ll share what we’ve discovered from past global health emergencies. What did we learn from Ebola, MERS, cholera, and how does it compare to the current coronavirus? How do we recover? We’ll also wrap up with the latest headlines on Pfizer's response to the crisis. New host Lindsey Dietschi speaks with Dr. David Swerdlow, Clinical Epidemiology Lead for Pfizer Vaccines and infectious disease expert. Prior to Pfizer, David worked at the Centers for Disease Control (CDC) for 25 years.Episo...2020-05-1918 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association Les Amis de MikhyL'association Les Amis de Mikhy libère la parole sur la souffrance des enfants malades, suite à la disparition de Mikhael, 10 ans, atteint d’un Gliome infiltrant du tronc cérébral.2020-05-1804 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association Autistes sans FrontièresL'association permet à de jeunes enfants autistes d’aller à l’école ordinaire, grâce à des accompagnateurs spécialisés.2020-05-1802 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association L'Etoile de MartinL'association L'étoile de Martin soutient la recherche sur les cancers de l’enfant et offre des moments de bien-être aux jeunes malades hospitalisés.2020-05-1804 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association LHF EspoirL'association LHF Espoir soutient les patients atteints de LHF (LymphoHistiocytose Familiale).2020-05-1806 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association SLA Aide et SoutienL'association SLA Aide et Soutien soutient les personnes atteintes de la maladie de Charcot (Sclérose Latérale Amyotrophique) et leur famille.2020-05-1805 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association Vivre comme avantL'association Vivre comme Avant permet aux femmes confrontées au cancer du sein de se sentir écoutées et comprises.2020-05-1805 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association ASAP for ChildrenL'association ASAP for Children soutient des enfants atteints de SMA-PME, maladie orpheline, génétique et neurodégénérative.2020-05-1807 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association 4SL'association 4S - Sport Santé Solidarité Savoie lutte contre le cancer du sein : sensibiliser au dépistage et soutenir les personnes atteintes de la maladie via le sport, l'écoute et la solidarité, tel est leur credo !2020-05-1805 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association AMVFL'association AMVF communique sur les pathologies rares des vaisseaux du foie et cherche à améliorer la vie des malades en soutenant la recherche scientifique.2020-05-1805 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association Mécénat Chirurgie CardiaqueL'association Mécénat Chirurgie Cardiaque fait venir des enfants souffrant de malformations cardiaques en France pour les opérer lorsqu'ils ne peuvent être soignés dans leur pays d'origine.2020-05-1807 min
Big Challenge for Patients by PfizerBig Challenge for Patients, by Pfizer - Association Chanter Marcher VivreL'association Chanter Marcher Vivre sensibilise les futures mamans et le monde médical sur le CMV (Cytomégalovirus) qui s'attrape pendant la grosesse.2020-05-1805 min
Women's Healthmenopause: unmuted: Sharing Stories"However, you experience menopause, it’s so important to remember you’re not alone." In the the final episode of season one, Dr Mary Jane Minkin shares some of her story highlights.menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Linkshttp://menopauseunmuted.comhttps://www.pfizer.com/health-wellness/diseases-conditions/menopause
2020-04-2822 min
Women's Healthmenopause: unmuted: Rebecca's StoryE5: Rebecca’s StoryOf all the symptoms she experienced, Rebecca felt powerless to combat the weight she gained. Rebecca’s story is about switching focus to celebrating the power and capabilities of a woman’s body and sharing her experience with her two teenage girls. “I found if you bring the people who are closest to you into what's happening, and you talk about it, it's so much easier.”menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment...2020-04-2820 min
Women's Healthmenopause: unmuted: Kathie's StoryE4: Kathie’s StoryKathie experienced menopause in her 30s, induced by a partial hysterectomy. Now aged 54, her story is about becoming a cheerleader for her friends experiencing menopause and being there to talk and help them stay positive throughout this next phase of life. “I'm able to give them a sense that it's not the end of the world.”menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Links • http://menopauseunmuted.com• ht...2020-04-2820 min
Women's Healthmenopause: unmuted: Charlene's StoryE3: Charlene’s StoryWith the sudden onset of menopause, Charlene’s story is about her taking control, changing the way she worked to help manage hot flashes, and finding ways to manage her anxiety. In hindsight she wished she’d been more vocal. “There's usually someone that's listening. So, don't stop talking.”menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Linkshttp://menopauseunmuted.comhttps://www.pfizer.com/health-wellness/diseases-conditions/menopause
2020-04-2817 min
Women's Healthmenopause: unmuted: Rachel's StoryE2: Rachel’s StoryFrom feeling invisible to invincible, Rachel’s story is about trying to navigate the emotional turbulence and physical changes associated with menopause, while managing other personal pressures. “I'm a badass ... and badassery just gets more creative as you get older.”menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Links • http://menopauseunmuted.com• https://www.pfizer.com/health-wellness/diseases-conditions/menopause
2020-04-2821 min
Women's Healthmenopause: unmuted: Susan's StoryE1: Susan’s StorySusan’s story is about honesty of experience. She has no doubt that talking and sharing experiences with her friends and confiding in family and co-workers helped her navigate her way through menopause. “The more we talk about it … we're going to be able to break those barriers and break down those fences that have been placed before us.” menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option.Links• http://menopa...2020-04-2717 min
Big Challenge for Patients by PfizerBig Challenge for patients, by Pfizer - IntroductionLier l'engagement à la culture patient, c'est l'objectif de ce podcast : pendant 14 semaines, plongez dans l'univers de 14 associations de patients soutenues par plus de 500 collaborateurs Pfizer dans le cadre du Big Challenge for Patients. Mais d'ailleurs, c'est quoi le Big Challenge for Patients ?2020-03-1103 minThe AntigenThe Antigen with Yasmeen Agosti - Launching in DecemberThe Antigen is an eight-part audio-documentary style podcast about the scientific, cultural, and political elements of vaccination. We start with the basic science, review vaccine history, explore the many facets of their global impact – and the public sentiment about vaccines around the world. Listeners will hear from leading experts about the past, present, and future of this important innovation, as well as people whose families have been impacted by vaccine-preventable diseases.The Antigen is hosted by Yasmeen Agosti, MD FAAP. Yasmeen is a pediatrician and a Global Medical Lead, Viral Vaccines at Pfizer. She is a Ph.D...2019-11-2101 min